1.Sresta Natural Bioproducts ltd IPO.
The Hyderabad-based organic food manufacturer Sresta Natural Bioproducts Ltd has submitted preliminary paperwork to SEBI in order to earn about Rs 500 crore through an initial share offering.
The company that owns the most well-known brand, “24 Mantra,” is Sresta Natural Bioproducts. It deals with the development, production, sale, and development of organic food items.
The initial public offering (IPO) consists of a fresh issue of equity shares worth up to Rs 50 crore and an offer-for-sale by the selling shareholders of up to 70.30 lakh equity shares.
It is also a well-known brand of organic Indian food in the USA. It will also be available on significant e-commerce platforms like Bigbasket in India and in 34 additional nations by 2021.The date has not been announced yet. But it will soon be released.
2.Sresta Natural Bioproducts ltd IPO Objectives.
1. Funding the working capital requirements of our Company.
2. Overarching business objectives.
3. Repaying or making partial payments in advance on a few outstanding unsecured/secured borrowings that the company has taken out.
4.Produced chemical free products.
3. Sresta Natural Bioproducts ltd Financials
Particulars | FY21 | FY20 | FY19 |
Revenue | 31.21 | 26.23 | 20.55 |
PAT | 1.04 | 0.95 | -0.35 |
EBITDA | 2.49 | 2.37 | 0.62 |
Total Assets | 19.36 | 16.95 | 15.89 |
Total Borrowings | 5.26 | 4.45 | 4.90 |
Share Capital | 1.83 | 1.83 | 1.82 |
4. key Factor of Sresta Natural Bioproducts ltd IPO
1.The Indian health and wellness market is anticipated to develop at a CAGR of 16% from Fiscal 2020 to Fiscal 2025, reaching roughly INR 1,27,290 crore in Fiscal 2025. Also beneficial as it produces organic products.
2.By 2030, it is anticipated that the Indian packaged food market would account for 20.2% of the global food and grocery sector.
5.Pros and Cons Of Sresta Natural Bioproducts ltd IPO.
Pros
1. One of the leading Indian food brand in many countries (35 countries)such as USA.
2. A pan-Indian footprint and market domination are supported by an omnichannel distribution network.
3. A quality-driven, asset-light strategy with processing facilities positioned strategically and total command over the supply chain.
4. The health industry grows so aggressively that it is beneficial for Sresta Natural Bioproducts ltd IPO.
Cons
1.If growers, aggregators, etc. are unable to supply enough organic agricultural products, it could have a detrimental effect.
2.the deterioration and damage of such items or raw materials as a result of inappropriate handling, processing, or storage of the products or raw materials.
DISCAMER
~ Please check the financials of the company before investing in company IPO.
~ We are not responsible for any inconvenience made by you; take your own risk.
~ Check all the aspects of investing in IPO. It’s your money; keep it safe.
NOTE~ The information given above is based 100% on research. Please conduct thorough research before Making an investment. We are not responsible if there is any loss caused by this information.